PROQR THRAPEUTICS N V's ticker is PRQR and the CUSIP is N71542109. A total of 43 filers reported holding PROQR THRAPEUTICS N V in Q3 2020. The put-call ratio across all filers is 6.00 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $118,999 | +71.6% | 55,868 | +198.0% | 0.00% | – |
| Q4 2022 | $69,364 | +433.6% | 18,747 | +4.0% | 0.00% | – |
| Q3 2022 | $13,000 | -88.7% | 18,025 | -87.8% | 0.00% | – |
| Q2 2022 | $115,000 | +447.6% | 147,558 | +550.4% | 0.00% | – |
| Q1 2022 | $21,000 | -84.8% | 22,689 | +32.1% | 0.00% | – |
| Q4 2021 | $138,000 | +43.8% | 17,174 | +49.6% | 0.00% | – |
| Q3 2021 | $96,000 | -90.2% | 11,482 | -92.3% | 0.00% | – |
| Q1 2021 | $982,000 | +1593.1% | 148,693 | +975.1% | 0.00% | – |
| Q4 2020 | $58,000 | 0.0% | 13,831 | +15.1% | 0.00% | – |
| Q3 2020 | $58,000 | -37.0% | 12,012 | +18.5% | 0.00% | – |
| Q2 2019 | $92,000 | – | 10,134 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 748,861 | $6,815,000 | 2.37% |
| Opus Point Partners Management, LLC | 138,461 | $1,260,000 | 1.86% |
| RTW INVESTMENTS, LP | 3,722,950 | $33,879,000 | 1.81% |
| Kerrisdale Advisers, LLC | 465,580 | $4,237,000 | 1.52% |
| DAFNA Capital Management LLC | 261,521 | $2,380,000 | 0.90% |
| SPHERA FUNDS MANAGEMENT LTD. | 470,000 | $4,277,000 | 0.58% |
| Artal Group S.A. | 1,300,000 | $11,830,000 | 0.48% |
| Orbimed Advisors | 1,382,502 | $12,581,000 | 0.20% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 56,000 | $511,000 | 0.19% |
| ALTRINSIC GLOBAL ADVISORS LLC | 201,360 | $1,832,000 | 0.08% |